The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer Patients
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
- Multifactorial pathogenesis is involved in anemia of cancer patients and defining the
causes of anemia is not always simple.
- Currently, treatment options available for anemia in cancer patients include red blood
cell (RBC) transfusion, erythropoietin stimulating agent (ESA), and iron
supplementation, accompanying considerable pros and cons for each treatment.
- Previous studies have demonstrated benefit when treating with IV iron in combination
with ESA and, more recently, evidence is emerging to suggest a role for IV iron alone.
- In this study, investigator will assess the efficacy of intravenous iron for the
treatment of anemia in cancer patients.